ARTICLES BY LAURIE HALLORAN
-
The 3 Secrets To Becoming an Effective Leader In Clinical Research3/16/2021
Experience in clinical research provides a solid foundation, which better positions you to launch your career into management- and executive-level roles. However, you will move away from operational execution and will be called to develop the skillsets and level of confidence required to lead and guide teams. What are the 3 skillsets to understand, develop, and refine your journey?
-
Moving Up The Ladder In Clinical Research: How To Develop Management & Leadership Skills1/26/2021
One of the biggest career jumps is from individual contributor to manager. Becoming comfortable with making more abstract contributions rather than providing tangible work and checking off your accomplishments is paramount.
-
Transformative Reflections On The Life Science World, Post-COVID-197/1/2020
I’m reflecting on life after COVID-19, a couple years out — based on need and capacity to respond. While unorthodox, reflecting on a future possible outcome offers insight to the achievable and the opportunity to prepare for future clinical needs using current expertise and treatments.
-
Clinical Study Conduct During The COVID-19 Pandemic — Challenges & Solutions4/6/2020
Life science companies across the world are scrambling to mitigate the impacts of COVID-19 on their clinical studies and business operations, and there are no clear-cut answers at this time, nor a one-size-fits-all solution. But what we do know is that we are all in this together and that this is another challenge that the biotech industry was built for.
-
Assessing The Impact Of COVID-19 On Regulatory Interactions, Inspections, & Audits3/19/2020
While we have not seen any significant delays in regulatory approval of life science products to date, the impact of COVID-19 on regulatory interactions, inspections, audits, and global health authorities is continuing to evolve.
-
8 Significant Risks COVID-19 Poses To Clinical Trials — And How To Mitigate Them3/19/2020
The impact of COVID-19 on clinical trials has been immediate, due to challenges posed by travel bans, hospital/clinic visitation restrictions, and social distancing precautions, just to name a few. These factors have translated into multiple issues that pose challenges related to corporate milestones, budgets, and data integrity.
-
Can New York City Lead In Life Sciences?9/7/2017
New York City has long aspired to become a life sciences hub, but while the city seems to have all the elements necessary to foster such industry growth, it has continually fallen short of this goal.